Pariza, MW, Park, Y & Cook, ME (1999) Conjugated linoleic acid and the control of cancer and obesity. Toxicol Sci 52, 107–110.
Pariza, M, Ashoor, S, Chu, F & Lund, D (1979) Effects of temperature and time on mutagen formation in pan-fried hamburger. Cancer Lett 7, 63–69.
Zu, HX & Schut, HA (1992) Inhibition of 2-amino-3-methylimidazol (4,5-f) quinoline-DNA adduct formation in CDF1 mice by heat-altered derivatives of linoleic acid. Food Chem Toxicol 30, 9–16.
Ip, C, Singh, M, Thompson, HJ & Scimeca, JA (1994) Conjugated linoleic acid suppresses mammary carcinogenesis and proliferative activity of the mammary gland in the rat. Cancer Res 54, 1212–1215.
Liew, C, Schut, HA, Chin, SF, Pariza, MW & Dashwood, RH (1995) Protection of conjugated linoleic acids against 2-amino-3-methylimidazol (4,5-f) quinoline-induced colon carcinogenesis in the F344 rat: a study of inhibitory mechanisms. Carcinogenesis 16, 3037–3043.
Schonberg, S & Krohan, HE (1995) The inhibitory effect of conjugated dienoic derivatives (CLA) of linoleic acid on the growth of human tumor cell lines is in part due to increased lipid peroxidation. Anticancer Res 15, 1241–1246.
Cunningham, DC, Harrison, LY & Shultz, TD (1997) Proliferative responses of normal human mammary and MCF-7 breast cancer cells to linoleic acid, conjugated linoleic acid and eicosanoid synthesis inhibitors in culture. Anticancer Res 17, 197–203.
Wong, MW, Chef, BP, Wong, TS, Hosick, HL, Boylston, TD & Schultz, TD (1997) Effects of dietary conjugated linoleic acid on lymphocyte function and growth of mammary tumors in mice. Anticancer Res 17, 987–993.
Lee, KN, Kritchevsky, D & Pariza, MW (1994) Conjugated linoleic acid and atherosclerosis in rabbits. Atherosclerosis 108, 19–25.
Miller, C, Park, Y, Pariza, MW & Cook, M (1994) Feeding conjugated linoleic acid to animals partially overcomes catabolic responses due to endotoxin injection. Biochem Biophys Res Commun 198, 1107–1112.
West, DB, Delany, JP, Camet, PM, Blohm, F, Truett, AA & Scimeca, J (1998) Effects of conjugated linoleic acid on body fat and energy metabolism in mouse. Am J Physiol 275, R667–R672.
Park, Y, Allbright, KJ, Liu, W, Storkson, JM, Cooj, ME & Pariza, MW (1997) Effects of conjugated linoleic acid on body composition in mice. Lipids 32, 853–858.
German, JB, Dilard, CJ & Ward, RE (2002) Bioactive components in milk. Curr Opin Clin Nutr Metab Care 5, 653–658.
Yu, L, Adams, D & Watkins, BA (2003) Comparison of commercial supplements containing conjugated linoleic acids. J Food Composit Anal 16, 419–428.
Nagao, K & Yanagita, T (2005) Conjugated fatty acids in food and their health benefits. J Biosci Bioeng 100, 152–157.
Gaullier, JM, Berven, G, Blankson, H & Gudmundsen, O (2002) Clinical trial results support a preference for using CLA preparations enriched with two isomers rather than four isomers in human studies. Lipids 37, 1019–1025.
Blankson, H, Stakkestad, JA, Fagertum, H, Thom, E, Wadstein, J & Gudmunsen, O (2000) Conjugated linoleic acid reduces body fat mass in overweight and obese humans. J Nutr 130, 2943–2948.
Smedman, A & Vessby, B (2001) Conjugated linoleic acid supplementation in humans – metabolic effects. Lipids 36, 773–781.
Thom, E, Wadstein, J & Gudmunsen, O (2001) Conjugated linoleic acid reduces body fat in healthy exercising humans. J Int Med Res 29, 392–396.
Riserús, U, Arner, P, Brismar, K & Vessby, B (2002) Treatment with dietary trans-10 cis-12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with metabolic syndrome. Diabetes Care 25, 1516–1521.
Berven, G, Bye, A, Hals, O & Karlsen, OA (2000) Safety of conjugated linoleic acid (CLA) in overweight or obese human volunteers. Eur J Lipid Sci Technol 102, 455–462.
Zambell, KL, Keim, NL, Van Loan, MD, Gale, B, Benito, P, Kelley, DS & Nelson, GJ (2000) Conjugated linoleic acid supplementation in humans: effects on body composition and energy expenditure. Lipids 35, 777–782.
Riserús, U, Berglund, L & Vessby, B (2001) Conjugated linoleic acid (CLA) reduced abdominal adipose tissue in obese middle-aged men with signs of metabolic syndrome: a randomised controlled trial. Int J Obes Relat Metab Disord 25, 1129–1135.
Kamphuis, MM, Lejeune, MP, Saris, WH & Westerterp-Plantenga, MS (2003) The effect of conjugated linoleic acid supplementation after weight loss on body weight regain, body composition, and resting metabolic rate in overweight subjects. Int J Obes Relat Metab Disord 27, 840–847.
Malpuech-Brugere, C, Verboeket-van de Venne, WP, Mensink, RP, Arnal, MA, Morio, B, Brandolini, M, Saebo, A, Lassel, TS, Chardigny, JM, Sebedio, JL & Beaufrere, B (2004) Effects of two conjugated linoleic acid isomers on body fat mass in overweight humans. Obes Res 12, 591–598.
Craig, CL, Marshall, Al, Sjostrom, M, Bauman, AE, Booth, ML, Ainsworth, BE, Pratt, M, Ekelund, U, Yngve, A, Sallis, JF & Oja, P (2003) International Physical Activity Questionnaire (IPAQ): 12-country reliability and validity. Med Sci Sports Exer 35, 1381–1395.
Gaullier, JM, Halse, J, Hoye, K, Kristiansen, K, Fagertun, H, Vik, H & Gudmundsen, O (2004) Conjugated linoleic acid supplementation for 1 year reduces body fat mass in healthy overweight humans. Am J Clin Nutr 79, 1118–1125.
Gaullier, JM, Halse, J, Hoye, K, Kristiansen, K, Fagertun, H, Vik, H & Gudmundsen, O (2005) Supplementation with conjugated linoleic acid for 24 months is well tolerated by and reduces body fat mass in healthy, overweight humans. J Nutr 135, 778–784.
Pariza, MW, Park, Y & Cook, ME (2001) The biologically active isomers of conjugated linoleic acid. Prog Lipid Res 40, 283–298.
Park, Y, Storckson, JM, Albright, KJ, Liu, W & Pariza, MW (1999) Evidence that the trans-10,cis-12 isomers of conjugated linoleic acid induces body composition changes in mice. Lipids 34, 235–241.
Evans, M, Geigerman, C, Cook, J, Curtis, L, Kuebler, B & McIntosh, M (2000) Conjugated acid linoleic suppresses triglyceride accumulation and induces apoptosis in 3T3-L1 preadipocytes. Lipids 35, 899–910.
Park, Y & Pariza, MW (2001) The effects of dietary conjugated nonadecadienoic acid and body composition in mice. Biochim Biophys Acta 1533, 171–174.
Kallen, C & Lazar, M (1996) Antidiabetic thiazolidinediones inhibit leptin on gene expression in 3T3-L1 adipocytes. Proc Natl Acad Sci USA 93, 5793–5796.
Granlud, L, Juvet, L, Pedersen, J & Nebb, H (2003) Trans 10, cis 12-conjugated linoleic acid prevents triacylglycerol accumulation in adipocytes by acting as a PPARgamma modulator. J Lipid Res 44, 1441–1452.
Szymczyk, B, Pisulewski, PM, Szczurek, W & Hanczakowski, P (2001) Effects of conjugated linoleic acid on growth performance, feed conversion efficiency, and subsequent carcass quality in broiler chickens. Br J Nutr 85, 465–473.
Salas-Salvado, J, Marquez-Sandoval, F & Bullo, M (2006) Conjugated linoleic acid intake in humans: a systematic review focusing on its effect on body composition, glucose, and lipid metabolism. Crit Rev Food Sci Nutr 46, 479–488.
Tricon, S, Burdge, G, Kew, S, et al. (2004) Opposing effects of cis-9,trans-11 and trans-10,cis-12 conjugated linoleic acid on blood lipids in healthy humans. Am J Clin Nutr 80, 614–620.
Noone, EJ, Roche, HM, Nugent, AP & Gibney, MJ (2002) The effect of dietary supplementation using isomeric blends of conjugated linoleic acid on lipid metabolism in healthy human subjects. Br J Nutr 88, 243–251.
Basu, S, Riserús, U, Turpeinen, A & Vessby, B (2000) Conjugated linoleic acid induces lipid peroxidation in men with abdominal obesity. Clin Sci 99, 511–516.
Basu, S, Smedman, A & Vessby, B (2000) Conjugated linoleic acid induces lipid peroxidation in humans. FEBS Lett 468, 33–36.
Tsuboyama-Kasaoka, N, Takahashi, M, Tanemura, K, Kim, HJ, Tange, T, Okuyama, H, Kasai, M, Ikemoto, S & Ezaki, O (2000) Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes 49, 1534–1542.